Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
40 pages
Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
64 pages
Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
132 pages
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Devel...
May 2022
36 pages
Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target,...
May 2022
74 pages
Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
45 pages
Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...
May 2022
38 pages
Venezuelan Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Venezuelan Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Venezuelan Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA,...
May 2022
42 pages
Venous Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Venous Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Venous Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
59 pages
Venous (Vein) Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Venous (Vein) Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Venous (Vein) Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
49 pages
Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA,...
May 2022
43 pages
Visceral Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Visceral Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Visceral Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
70 pages
Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...
May 2022
44 pages
Vulvar Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Vulvar Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vulvar Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
76 pages
Vulvovaginal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Vulvovaginal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vulvovaginal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
44 pages
West Nile Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
West Nile Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY West Nile Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule...
May 2022
50 pages
Wilms Tumor (Nephroblastoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Wilms Tumor (Nephroblastoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Wilms' Tumor (Nephroblastoma) Drugs in Development by Stages, Target, MoA, RoA, Mol...
May 2022
43 pages
Wiskott-Aldrich Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Wiskott-Aldrich Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Wiskott-Aldrich Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
35 pages
X-Linked SCID Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
X-Linked SCID Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY X-Linked SCID Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
38 pages
Xerostomia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Xerostomia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Xerostomia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...
May 2022
39 pages
